Table 3 Diagnostic measures at various cutoff points for the prediction of non-response to treatment
From: Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes
Predictors, Cutoff point | TP/FP | TN/FN | Sensitivity | Specificity |
|---|---|---|---|---|
Average preprandial glucose level over 2 days after the initiation of GLP-1 receptor agonist treatment (mg/dL) | ||||
<120 | 26/12 | 5/0 | 100 | 29.4 |
<130 | 25/11 | 6/1 | 96.2 | 35.3 |
<140 | 21/7 | 10/5 | 80.8 | 58.8 |
<150 | 15/6 | 11/11 | 57.7 | 64.7 |
<160 | 10/5 | 12/16 | 38.5 | 70.6 |
<170 | 9/3 | 14/17 | 34.6 | 82.4 |
<180 | 8/1 | 16/18 | 30.8 | 94.1 |
<190 | 6/0 | 17/20 | 23.1 | 100.0 |
<200 | 4/0 | 17/22 | 15.4 | 100.0 |